arrow
L

Lukáš Rob

university hospital kralovske vinohrady and charles university
H指数:40
被引数:5,377

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pretreatment computed tomography L1 attenuation values: Easy reaching predicting factor for radiation-related bone insufficiency fractures in females treated for advanced cervical cancer (prospective study)

术前L1椎体CT衰减值:预测接受晚期宫颈癌治疗女性患者发生放疗相关性骨性不足骨折的易达预测因子(前瞻性研究)

2026-02-260
PRE
Molecular impact of NOTCH signaling dysregulation on ovarian cancer progression, chemoresistance, and taxane response

NOTCH信号通路失调对卵巢癌进展、化疗耐药及紫杉烷类药物反应的分子影响

2025-09-080
PREAI
Functional validation of somatic variability in TP53 and KRAS for prediction of platinum sensitivity and prognosis in epithelial ovarian carcinoma patients

TP53和KRAS体细胞变异的功能验证,用于预测上皮性卵巢癌患者的铂类药物敏感性和预后

2025-08-100
OAAI
Safety and efficacy of the therapeutic DNA-based vaccine VB10.16 in combination with atezolizumab in persistent, recurrent or metastatic HPV16-positive cervical cancer: a multicenter, single-arm phase 2a study

VB10.16治疗性DNA疫苗与atezolizumab联合用于持续性、复发性或转移性HPV16阳性宫颈癌的安全性和有效性:一项多中心、单臂2a期研究

2025-01-071
OA
ENGOT-en11/GOG-3053/KEYNOTE-B21: A phase III study of pembrolizumab or placebo in combination with adjuvant chemotherapy with or without radiotherapy in patients with newly diagnosed, high-risk endometrial cancer

ENGOT-en11/GOG-3053/KEYNOTE-B21: 一项关于帕博利珠单抗或安慰剂联合辅助化疗,且根据情况联合或不联合放疗,在 newly diagnosed、high-risk endometrial cancer 患者中进行的 III 期研究

2024-09-010
PRE
Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer

三级淋巴结构和b细胞决定卵巢癌的临床相关T细胞表型

2024-03-2113
OAAI
Targeted DNA sequencing of high-grade serous ovarian carcinoma reveals association of TP53 mutations with platinum resistance when combined with gene expression

高级别浆液性卵巢癌的靶向DNA测序揭示了TP53突变与铂类耐药的关联,当与基因表达结合时

2024-03-061
OA
Peripheral gene signatures reveal distinct cancer patient immunotypes with therapeutic implications for autologous DC-based vaccines
2022-07-2212
OA